EIGER BIOPHARMACEUTICALS INC — Form D/A
EIGER BIOPHARMACEUTICALS INC of Santa Clara, CA, a company, filed a Form D amendment with the SEC on 2010-09-20. The offering totals $8.3M, of which $8.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-09-20
- Form: D/A
- Accession: 0001454815-10-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.3M
- Amount sold: $8.3M
- Investors: 9
- Date of first sale: 2008-12-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-126345
Issuer
- Name: EIGER BIOPHARMACEUTICALS INC
- CIK: 0001454815
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1115 Lafayette St., Santa Clara, CA, 95050
- Phone: 650-804-8553
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Keith Vendola | Executive Officer | St. Louis, MO |
| Wenjin Yang | Executive Officer | Redwood City, CA |
| Nina Kjellson | Director | Santa Clara, CA |
| Thomas Dietz | Director | Research Triangle Park, NC |
| Glen Sato | Executive Officer | Santa Clara, CA |
| David Cory | Director | Santa Clara, CA |
| David Cory | Executive Officer | Santa Clara, CA |
| Ed Engleman | Director | Santa Clara, CA |
| Jeffrey Glenn | Director | Santa Clara, CA |
| Paul Truex | Director | Santa Clara, CA |
Other filings by this issuer (9)
More